Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Clinical OutsourcingClinical Outsourcing
Not Confirmed
Not Confirmed
03-04 March, 2026
Natural Product Expo W...Natural Product Expo West
Not Confirmed
Not Confirmed
03-06 March, 2026
Natural Products ExpoNatural Products Expo
Not Confirmed
Not Confirmed
03-06 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Clinical OutsourcingClinical Outsourcing
Industry Trade Show
Not Confirmed
03-04 March, 2026
Natural Product Expo W...Natural Product Expo West
Industry Trade Show
Not Confirmed
03-06 March, 2026
Natural Products ExpoNatural Products Expo
Industry Trade Show
Not Confirmed
03-06 March, 2026
Digital content

29 Dec 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/adventures-in-dmpk-viva-biotechs-one-stop-pharmacology-platform-cross-new-modalities-302650048.html

29 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/viva-biotech-receives-frost--sullivans-2025-apac-technology-innovation-leadership-recognition-in-the-integrated-intelligent-drug-discovery-industry-302569339.html

02 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/unlocking-the-potential-of-cyclic-peptide-therapeutics-viva-biotechs-discovery-insights-302543648.html

28 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/viva-biotech-announces-its-2025-interim-results-cro-revenue-returned-to-positive-growth-new-cdmo-commercialization-projects-showed-promising-growth-302540971.html

28 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/viva-biotechs-wholly-owned-subsidiary-langhua-pharmaceutical-successfully-passes-us-fda-on-site-inspection-302414114.html

08 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/latest-updates-of-viva-biotechs-portfolio-companies-302345738.html
ABOUT THIS PAGE